Place of Origin: | China |
Brand Name: | Phytocare |
Minimum Order Quantity: | Negotiation |
---|---|
Price: | Negotiation |
Packaging Details: | 25kg/drum |
Payment Terms: | L/C, D/A, D/P, T/T, PAYPAL |
Supply Ability: | 5000kg/month |
Product Name: | Citicoline | CAS No.: | 987-78-0 |
---|---|---|---|
Synonyms: | Cytidine Diphosphate-Choline | Grade: | Food, Pharmaceutical |
Test Method: | HPLC | Origin: | China |
Highlight: | CAS 987-78-0 Citicoline Powder,Brain Surgery Citicoline Powder,Acute Craniocerebral Trauma Citicoline Powder |
Citicoline Powder CAS: 987-78-0 for Consciousness disorders after acute craniocerebral trauma and brain surgery
Product Name: Citicoline
Synonyms: Cytidine diphosphate-choline; CDP-Choline; Cytidine 5'-diphosphocholine
Product Name | Citicoline |
CAS No. | 987-78-0 |
Items | Standards |
Appearance | White crystalline powder, odorless |
PH | 2.5~3.5 |
Clarity and color | Colorless to clarify |
Loss on drying | ≤5.0% |
Heavy metals | ≤10 ppm |
Pb | ≤3 ppm |
As | ≤2 ppm |
Hg | ≤0.1 ppm |
Cd | ≤1 ppm |
Assay (HPLC) | 98.0%~102.0% |
Purity (HPLC) | ≥98.0% |
Cytidine 5’-monophosphate, free acid | ≤1.0% |
Free phosphoric acids | ≤0.01% |
Total bacterial count | ≤1,000 CFU/g |
Yeast and Molds | ≤100 CFU/g |
E. Coli | Negative |
Salmonella | Negative |
Storage | Keep in cool dry place, avoid direct sun and heat |
Shelf life | 2 years from the original packaging |
Medical Use:
Mainly used for consciousness disorders after acute craniocerebral trauma and brain surgery.
Disturbance of consciousness in acute stage of cerebral infarction.
Used for ischemic cerebrovascular disease, vascular dementia, tinnitus and neurogenic deafness.
It can also be applied to coma and disturbance of consciousness caused by acute poisoning, infection and large-area cerebral infarction.
It is helpful for the recovery of upper and lower limb functions of stroke sequelae and post-stroke hemiplegia patients, and can be used with drugs that promote brain metabolism and cerebral circulation.
Food Dietary Supplement Application:
Conducive to brain development, helps regulate cognitive function, smoothes neuronal communication, and protects neural structures from free radicals. Treat cognitive impairment in the elderly (secondary to neurodegenerative diseases, such as Alzheimer's disease, and chronic cerebrovascular diseases). Improve the score of cognitive assessment scale in patients with chronic cerebral ischemia; in patients with Alzheimer's disease, it can slow down the development of the disease.
Improve brain function and reduce cerebrovascular resistance.
Improve short-term and long-term memory.
Further Development:
The efficacy and safety of citicoline in the treatment of nerve injury have been confirmed by a large number of clinical practice and medical evidence. Citicoline has become a promising drug and health care product for nerve protection and nerve repair. In the United States and Canada, citicoline has been legislated to be used as a nutritional supplement for daily use. In China, citicoline is still a prescription drug and can not be purchased at will. However, according to the newly issued national food safety standard infant formula (GB 10765-2021), choline has been modified from optional ingredients to essential ingredients. It is believed that there will be relevant policies to vigorously promote its use in health products and nutritional supplements.
Contact Person: Ms. Chen
Tel: +8613704033823